SORTIS Invest Advised KDTB Research on the Fundraising for a New Antibiotic for Tuberculosis

SORTIS Invest Advised KDTB Research on the Fundraising for a New Antibiotic for Tuberculosis

KDTB Research, a drug development start-up developing a new medicine for treatment of Tuberculosis, closed a successful funding round with the assistance of SORTIS Invest. The financing was led by Innovation Capital – a venture capital fund located in Sofia, Bulgaria. KDTB Research is a company that specializes in developing superior drugs for treatment of […]

>> SORTIS Invest Advised KDTB Research on the Fundraising for a New Antibiotic for Tuberculosis
BASF to acquire Bayer-Crop Science Business for €5.9 Bn

BASF to acquire Bayer-Crop Science Business for €5.9 Bn

BASF SE agreed to acquire the Crop Science Business of Bayer AG, a Leverkusen-based manufacturer of organic chemicals, for €5.9 Bn ($7.0 Bn) in cash. Bayer decided to divest its seed and non-selective herbicide business in an effort to alleviate authorities’ anti-trust concerns and gain approval for its takeover of Monsanto, an agrochemical and agricultural […]

>> BASF to acquire Bayer-Crop Science Business for €5.9 Bn